This page follows insider dealings at Pharmadrug Inc. as filed with SEDI, a company from the Health Care sector. The past year has been quiet: not a single insider filing for Pharmadrug Inc. The previous disclosure was published on 14 October 2025.
Our records for Pharmadrug Inc. go back to 2020, with no purchases and 2 sales on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
15 of 15 declarations
Pharmadrug Inc. is a company focused on the development and commercialization of pharmaceutical products. It is listed on the Toronto Stock Exchange (XTSE).
Purchases our model currently ranks for the recommendations list.
All recommendations